AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 30383139 — intervention group
Group type: COMPARATOR
Intervention: Roux-en-Y gastric bypass (RYGB) vs Adjustable gastric banding (AGB)
Number of subjects: 65093
Study 30383139 — intervention group
Group type: COMPARATOR
Intervention: Sleeve gastrectomy (SG) vs Adjustable gastric banding (AGB)
Number of subjects: 65093
Study 30383140 — intervention group
Group type: EXPERIMENTAL
Intervention: Imatinib, 400 mg once daily, orally for 5 years
Number of subjects: 91
Study 30383276 — intervention group
Group type: EXPERIMENTAL
Intervention: Complementary Feeding Utility Index (CFUI) for 7-12 months
Number of subjects: 6000
Study 30383276 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Eating Index-2015 (HEI-2015) for 13 and 24 months
Number of subjects: 6000
Study 30383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological-based acculturation
Number of subjects: 1194
Study 30383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Language-based scale
Number of subjects: 1194
Study 30383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological-based scale
Number of subjects: 1194
Study 30383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Years living in the mainland United States
Number of subjects: 1194
Study 30383277 — intervention group
Group type: EXPERIMENTAL
Intervention: Income >$25,000
Number of subjects: 1194
Study 30383277 — intervention group
Group type: COMPARATOR
Intervention: No associations
Number of subjects: 1194
Study 30383280 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower saturated fat intake
Number of subjects: 564
Study 30383280 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased vegetable and fruit intake
Number of subjects: 564
Study 30383280 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiber intake
Number of subjects: 564
Study 30383482 — intervention group
Group type: EXPERIMENTAL
Intervention: Employer wellness programs for obesity management
Number of subjects: 3008
Study 30383482 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness and attitudes of employer representatives (ERs) regarding obesity management
Number of subjects: 3008
Study 30383482 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges in implementing workplace wellness programs
Number of subjects: 3008
Study 30383777 — intervention group
Group type: EXPERIMENTAL
Intervention: Benznidazole treatment (TrG)
Number of subjects: 493
Study 30383781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasted posture
Number of subjects: 22
Study 30383781 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-fasted posture
Number of subjects: 22
Study 30383781 — intervention group
Group type: EXPERIMENTAL
Intervention: Seated posture
Number of subjects: 22
Study 30383781 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting state
Number of subjects: 22
Study 30384320 — intervention group
Group type: EXPERIMENTAL
Intervention: Civil commitment for opioid use
Number of subjects: 292
Study 30384320 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-commitment medication treatment
Number of subjects: 292
Study 30384320 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived procedural justice during commitment hearing
Number of subjects: 292
Study 30384320 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitude and higher motivation at the end of commitment
Number of subjects: 292
Study 30384320 — intervention group
Group type: EXPERIMENTAL
Intervention: Improvement in attitude during commitment
Number of subjects: 292
Study 30384846 — intervention group
Group type: EXPERIMENTAL
Intervention: Past placental malaria exposure
Number of subjects: 313
Study 30384846 — intervention group
Group type: COMPARATOR
Intervention: Non-exposed control group
Number of subjects: 313
Study 30384846 — intervention group
Group type: EXPERIMENTAL
Intervention: TLR7/8 stimulation
Number of subjects: 313
Study 30385437 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihyperglycaemic medication
Number of subjects: 138
Study 30385437 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes-related comorbidity and higher mental component summary score in the SF-36
Number of subjects: 138
Study 30385437 — intervention group
Group type: EXPERIMENTAL
Intervention: General information needs
Number of subjects: 138
Study 30386184 — intervention group
Group type: EXPERIMENTAL
Intervention: Management training and toolkit for community-based organizations (CBOs)
Number of subjects: 31
Study 30386184 — intervention group
Group type: COMPARATOR
Intervention: Control group (no specific intervention mentioned)
Number of subjects: 31
Study 30386416 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver Qi Stagnation (LQS)
Number of subjects: 50
Study 30386416 — intervention group
Group type: EXPERIMENTAL
Intervention: Heart and Spleen Deficiency (HSD)
Number of subjects: 50
Study 30386416 — intervention group
Group type: COMPARATOR
Intervention: Healthy Controls
Number of subjects: 50
Study 30386591 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulmonary artery catheter (PAC) use
Number of subjects: 6844
Study 30386820 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized combined training (executive function and memory) for 96 sessions for more than 24 weeks
Number of subjects: 120
Study 30386820 — intervention group
Group type: COMPARATOR
Intervention: No intervention (waitlist control group)
Number of subjects: 120
Study 30386824 — intervention group
Group type: EXPERIMENTAL
Intervention: MRgRT dose adaptation
Number of subjects: 75
Study 30386824 — intervention group
Group type: COMPARATOR
Intervention: Standard IMRT
Number of subjects: 75
Study 30386863 — intervention group
Group type: EXPERIMENTAL
Intervention: Body Composition Assessment
Number of subjects: 0
Study 30387050 — intervention group
Group type: EXPERIMENTAL
Intervention: Early 7-day supplemental parenteral nutrition (SPN)
Number of subjects: 131
Study 30387527 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcolepsy type 1 (NT1) patients
Number of subjects: 0
Study 30387527 — intervention group
Group type: COMPARATOR
Intervention: ADNI group (control)
Number of subjects: 0
Study 30387527 — intervention group
Group type: COMPARATOR
Intervention: MAPT-AV45 group (control)
Number of subjects: 0
Study 30388073 — intervention group
Group type: EXPERIMENTAL
Intervention: Secukinumab 150 mg
Number of subjects: 197
Study 30388073 — intervention group
Group type: COMPARATOR
Intervention: Adalimumab 40 mg
Number of subjects: 197
Study 30388108 — intervention group
Group type: EXPERIMENTAL
Intervention: Single oral dose of 400 mg albendazole (ALB)
Number of subjects: 0
Study 30388108 — intervention group
Group type: EXPERIMENTAL
Intervention: Microscopic (duplicate Kato-Katz thick smear, Mini-FLOTAC, FECPAKG2) and molecular stool-based diagnostic methods (quantitative PCR)
Number of subjects: 0
Study 30388108 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA samples submitted for pyrosequencing
Number of subjects: 0
Study 30388966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exposure to extra vitamin D from food fortification
Number of subjects: 0
Study 30388966 — intervention group
Group type: EXPERIMENTAL
Intervention: Prenatal exposure to extra vitamin D from food fortification (spring-born women)
Number of subjects: 0
Study 30388966 — intervention group
Group type: COMPARATOR
Intervention: Unexposed women
Number of subjects: 0
Study 30389034 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP-21
Number of subjects: 300
Study 30389034 — intervention group
Group type: EXPERIMENTAL
Intervention: R-CHOP-14
Number of subjects: 300
Study 30389034 — intervention group
Group type: COMPARATOR
Intervention: R-CHOP-21 and R-CHOP-14
Number of subjects: 300
Study 30389348 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominant pain mechanism classification by two assessors
Number of subjects: 48
Study 30389348 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominant pain pattern classification by two assessors
Number of subjects: 48
Study 30389348 — intervention group
Group type: EXPERIMENTAL
Intervention: Predominant dysfunction pattern classification by two assessors
Number of subjects: 48
Study 30389550 — intervention group
Group type: EXPERIMENTAL
Intervention: Carvedilol prophylaxis
Number of subjects: 106
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-QST
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: NDS
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: NCS
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Small and medium fibers
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Large fiber deficits
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete loss of function in all fibers
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperalgesia
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: NSS
Number of subjects: 136
Study 30389624 — intervention group
Group type: EXPERIMENTAL
Intervention: Age and albuminuria
Number of subjects: 136
Study 30389646 — intervention group
Group type: EXPERIMENTAL
Intervention: Monthly motivational phone calls by a trained nutritionist and weekly tailored text messages over a 12-month period (high intervention uptake)
Number of subjects: 0
Study 30389649 — intervention group
Group type: EXPERIMENTAL
Intervention: Online integrated treatment (8 weeks, 12 modules based on cognitive behavioral therapy and motivational interviewing)
Number of subjects: 214
Study 30389649 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational control group (links to resources, access to full treatment after follow-up)
Number of subjects: 214
Study 30390114 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemoradiotherapy with deep regional hyperthermia (HCRT)
Number of subjects: 112
Study 30390170 — intervention group
Group type: EXPERIMENTAL
Intervention: Trastuzumab treatment
Number of subjects: 41
Study 30390395 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranolazine
Number of subjects: 0
Study 30390672 — intervention group
Group type: EXPERIMENTAL
Intervention: Anti-TNF-α treatment pre-operatively (n=18)
Number of subjects: 46
Study 30390672 — intervention group
Group type: COMPARATOR
Intervention: Anti-TNF-α naïve patients (n=28)
Number of subjects: 46
Study 30390698 — intervention group
Group type: EXPERIMENTAL
Intervention: Respiratory failure (RF)
Number of subjects: 100
Study 30390698 — intervention group
Group type: EXPERIMENTAL
Intervention: Pupillary response
Number of subjects: 100
Study 30390698 — intervention group
Group type: EXPERIMENTAL
Intervention: Injury severity score (ISS)
Number of subjects: 100
Study 30390698 — intervention group
Group type: EXPERIMENTAL
Intervention: Midline shift > 15 mm
Number of subjects: 100
Study 30390896 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrated Nutrition Pathway for Acute Care (INPAC) implementation
Number of subjects: 1250
Study 30390896 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard care activities implementation
Number of subjects: 1250
Study 30391776 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban
Number of subjects: 111
Study 30391776 — intervention group
Group type: COMPARATOR
Intervention: Vitamin K-antagonist (VKA)
Number of subjects: 111
Study 30391805 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin receptor-related genes and dopamine regulation-related genes in the dlPFC
Number of subjects: 321
Study 30391805 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin receptor-related genes and dopamine regulation-related genes in the hippocampus
Number of subjects: 321
Study 30391805 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin receptor gene (INSR)
Number of subjects: 321
Study 30391805 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin receptor substrate 1 and 2
Number of subjects: 321
Study 30392095 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9338
Study 30392095 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9338
Study 30392735 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose oral ondansetron
Number of subjects: 626
Study 30392735 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 626
Study 30392813 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperfractionated radiotherapy
Number of subjects: 338
Study 30392813 — intervention group
Group type: COMPARATOR
Intervention: Standard radiotherapy
Number of subjects: 338
Study 30392813 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapies (maximal surgical resection followed by adjuvant craniospinal irradiation and chemotherapy)
Number of subjects: 338
Study 30393106 — intervention group
Group type: EXPERIMENTAL
Intervention: Glecaprevir/pibrentasvir (300 mg/120 mg) orally once daily for 8 weeks (for patients without cirrhosis) or 12 weeks (for patients with compensated cirrhosis)
Number of subjects: 84
Study 30393582 — intervention group
Group type: EXPERIMENTAL
Intervention: Curative, normofractionated radiotherapy
Number of subjects: 18
Study 30393582 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study 30393621 — intervention group
Group type: EXPERIMENTAL
Intervention: Nivolumab and ipilimumab (CheckMate-227; NCT02477826)
Number of subjects: 0
Study 30393621 — intervention group
Group type: EXPERIMENTAL
Intervention: Atezolizumab (IMPower 150; NCT02366143)
Number of subjects: 0
Study 30393825 — intervention group
Group type: EXPERIMENTAL
Intervention: Pazopanib with low fat meal (LFM)
Number of subjects: 16
Study 30394330 — intervention group
Group type: EXPERIMENTAL
Intervention: KLG0 case knees with contralateral radiographic JSN
Number of subjects: 828
Study 30394330 — intervention group
Group type: COMPARATOR
Intervention: KLG0 reference knees
Number of subjects: 828
Study 30394330 — intervention group
Group type: EXPERIMENTAL
Intervention: KLG0 knees with contralateral KLG2 without JSN
Number of subjects: 828
Study 30394678 — intervention group
Group type: EXPERIMENTAL
Intervention: Long-term combined antiretroviral therapy (ART)
Number of subjects: 395
Study 30395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Inadequate perioperative prophylaxis in patients with established antibiotic treatment
Number of subjects: 438
Study 30395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Incisional surgical site infections
Number of subjects: 438
Study 30395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Hemorrhage
Number of subjects: 438
Study 30395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal insufficiency
Number of subjects: 438
Study 30395220 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure time increases of 1-hour intervals
Number of subjects: 438
Study 30396014 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous trastuzumab (H SC) 600 mg via handheld syringe
Number of subjects: 240
Study 30396014 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous trastuzumab (H SC) 600 mg via single-use injection device
Number of subjects: 240
Study 30396833 — intervention group
Group type: EXPERIMENTAL
Intervention: Phelan-McDermid syndrome patients
Number of subjects: 11
Study 30396865 — intervention group
Group type: EXPERIMENTAL
Intervention: Ezetimibe (10 mg per day) added to simvastatin (40 mg per day)
Number of subjects: 18144
Study 30396906 — intervention group
Group type: EXPERIMENTAL
Intervention: Bioceptive suction cervical retractor (SCR)
Number of subjects: 25
Study 30396906 — intervention group
Group type: COMPARATOR
Intervention: Standard single-tooth tenaculum
Number of subjects: 25
Study 30397066 — intervention group
Group type: EXPERIMENTAL
Intervention: Efavirenz-based antiretroviral therapy without any efavirenz dose adjustments in children with TB/HIV coinfection.
Number of subjects: 105
Study 30397066 — intervention group
Group type: COMPARATOR
Intervention: Efavirenz-based antiretroviral therapy without any efavirenz dose adjustments in children without TB.
Number of subjects: 105
Study 30397067 — intervention group
Group type: EXPERIMENTAL
Intervention: WCK 5222 (Cefepime-Zidebactam Combination)
Number of subjects: 48
Study 30397491 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes prevention program (D-CLIP)
Number of subjects: 550
Study 30397491 — intervention group
Group type: COMPARATOR
Intervention: Standard of care
Number of subjects: 550
Study 30397669 — intervention group
Group type: COMPARATOR
Intervention: sCAMs, MMP-9, TIMP-1, NE levels measured in serum
Number of subjects: 91
Study 30397669 — intervention group
Group type: COMPARATOR
Intervention: sCAMs and their sheddases
Number of subjects: 91
Study 30398220 — intervention group
Group type: EXPERIMENTAL
Intervention: Coronary angiography (CAG)
Number of subjects: 220
Study 30398220 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 220
Study 30398220 — intervention group
Group type: EXPERIMENTAL
Intervention: High-sensitivity cardiac troponin I (hs-cTnI) measurement
Number of subjects: 220
Study 30398220 — intervention group
Group type: EXPERIMENTAL
Intervention: Asymptomatic post-procedural elevated hs-cTnI levels
Number of subjects: 220
Study 30398222 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver component added to a life skills programme for adolescent girls (13 caregiver sessions)
Number of subjects: 1633
Study 30398222 — intervention group
Group type: COMPARATOR
Intervention: Life skills sessions for adolescent girls (32 sessions)
Number of subjects: 1633
Study 30398222 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver component added to a life skills programme for adolescent girls
Number of subjects: 1633
Study 30398223 — intervention group
Group type: EXPERIMENTAL
Intervention: Life skills and safe spaces programme (30 life skills sessions and 8 caregiver sessions)
Number of subjects: 919
Study 30398223 — intervention group
Group type: EXPERIMENTAL
Intervention: Life skills and safe spaces programme
Number of subjects: 919
Study 30398223 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 919
Study 30398516 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline sex hormone-binding globulin (SHBG) level among men
Number of subjects: 2169
Study 30398516 — intervention group
Group type: EXPERIMENTAL
Intervention: Sex steroids
Number of subjects: 2169
Study 30398516 — intervention group
Group type: EXPERIMENTAL
Intervention: Men with higher SHBG level
Number of subjects: 2169
Study 30398516 — intervention group
Group type: COMPARATOR
Intervention: Women
Number of subjects: 2169
Study 30400729 — intervention group
Group type: EXPERIMENTAL
Intervention: Daclatasvir (DCV) and Asunaprevir (ASV)
Number of subjects: 21
Study 30400780 — intervention group
Group type: EXPERIMENTAL
Intervention: Ixazomib in combination with carboplatin
Number of subjects: 41
Study 30400824 — intervention group
Group type: EXPERIMENTAL
Intervention: D-IBS patients
Number of subjects: 39
Study 30400824 — intervention group
Group type: COMPARATOR
Intervention: CD patients
Number of subjects: 39
Study 30400824 — intervention group
Group type: EXPERIMENTAL
Intervention: D-IBS(+) patients
Number of subjects: 39
Study 30400834 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 2000
Study 30400834 — intervention group
Group type: EXPERIMENTAL
Intervention: Repeated influenza vaccination
Number of subjects: 2000
Study 30400834 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza virus infections
Number of subjects: 2000
Study 30400834 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccine acceptance predictors
Number of subjects: 2000
Study 30400860 — intervention group
Group type: EXPERIMENTAL
Intervention: Audio-video recording during laparoscopic surgery
Number of subjects: 41
Study 30400860 — intervention group
Group type: COMPARATOR
Intervention: Video only recording
Number of subjects: 41
Study 30400864 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alendronate sodium 70 mg plus vitamin D3 5600 IU once weekly for 26 weeks
Number of subjects: 198
Study 30400864 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 198
Study 30400986 — intervention group
Group type: EXPERIMENTAL
Intervention: FoundationACT assay
Number of subjects: 81
Study 30401520 — intervention group
Group type: EXPERIMENTAL
Intervention: 18F-FDG PET/CT
Number of subjects: 78
Study 30401520 — intervention group
Group type: EXPERIMENTAL
Intervention: Male sex
Number of subjects: 78
Study 30401620 — intervention group
Group type: EXPERIMENTAL
Intervention: Pertussis vaccination
Number of subjects: 314
Study 30401620 — intervention group
Group type: EXPERIMENTAL
Intervention: Influenza vaccination
Number of subjects: 314
Study 30401620 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire responses from pregnant women
Number of subjects: 314
Study 30401620 — intervention group
Group type: EXPERIMENTAL
Intervention: Questionnaire responses from HCPs
Number of subjects: 314
Study 30401669 — intervention group
Group type: EXPERIMENTAL
Intervention: iQOS with HeatSticks
Number of subjects: 0
Study 30401669 — intervention group
Group type: COMPARATOR
Intervention: Conventional combustible cigarettes
Number of subjects: 0
Study 30402265 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity interval training (HIIT) for 11 weeks
Number of subjects: 61
Study 30402265 — intervention group
Group type: COMPARATOR
Intervention: Control group instructed to not change their physical exercise habits
Number of subjects: 61
Study 30402565 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate compression (weekly two-component compression bandages during chemotherapy)
Number of subjects: 0
Study 30402565 — intervention group
Group type: COMPARATOR
Intervention: Delayed compression (compression after chemotherapy)
Number of subjects: 0
Study 30402565 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate compression
Number of subjects: 0
Study 30402565 — intervention group
Group type: COMPARATOR
Intervention: Delayed compression
Number of subjects: 0
Study 30402593 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcium supplementation integrated into ANC services
Number of subjects: 32
Study 30402593 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence partners providing reminders and support
Number of subjects: 32
Study 30402593 — intervention group
Group type: EXPERIMENTAL
Intervention: Challenges in adherence to calcium supplementation
Number of subjects: 32
Study 30402593 — intervention group
Group type: EXPERIMENTAL
Intervention: General acceptability of calcium supplementation
Number of subjects: 32
Study 30402594 — intervention group
Group type: EXPERIMENTAL
Intervention: Breakfast consumption
Number of subjects: 13
Study 30402594 — intervention group
Group type: COMPARATOR
Intervention: Skipping breakfast
Number of subjects: 13